Caribou Biosciences Inc.

CRBU | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.30

$0 (0.00%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

+$0.01 (+0.77%)

Pre-market: Sep 22, 2026, 9:13 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $128.93M

1D Range

1.29 1.35

52W Range

1.25 3.54

Valuation (TTM)

PE -1.20

PB 1.31

EV/EBITDA -0.42

Valuation (NTM)

Forward PE N/A

Forward PEG -0.04

Price Target $5

Cash Flow

FCF Yield -74.3%

SBC Adj. FCF Yield -82.4%

SBC Impact -11.0%

Margins

Gross Margin -129.7%

Operating Margin -1282.5%

FCF Margin -1121.7%

Growth (CAGR)

Revenue 3Y | 5Y -15.7% | 10.2%

Dil EPS 3Y | 5Y 10.9% | 6.2%

FCF 3Y | 5Y 15.2% | -5.4%

Returns

ROA -72.4%

ROE -89.1%

ROIC -86.3%

Financial Health

Net Cash

$85.66M

Current Ratio 6.49

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address b...

Sector Healthcare

Industry Biotechnology

Employees 97

IPO Date Jul 22, 2021

Website cariboubio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+284.62%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞